Intriguingly, whether the increased relative abundance of butyrate-producing gut bacteria (via fecal transplantation or probiotics) in homozygous or heterozygous APOE-ε4 individuals could decrease AD risk, halt AD progression, or repudiate AD remains to be elucidated. This evidence concerns the gene APOE and Alzheimer disease.